These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6422697)

  • 1. The dosage dependency of growth and maturity in growth hormone deficiency treated with human growth hormone.
    Vicens-Calvet E; Vendrell JM; Albisu M; Potau N; Audi L; Gusiñe M
    Acta Paediatr Scand; 1984 Jan; 73(1):120-6. PubMed ID: 6422697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.
    Smith PJ; Hindmarsh PC; Brook CG
    Arch Dis Child; 1988 May; 63(5):491-4. PubMed ID: 3389862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height and pubertal development in children with growth hormone deficiency after long-term treatment.
    Frisch H; Birnbacher R
    Horm Res; 1995; 43(4):132-4. PubMed ID: 7750913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone therapy with three dosage regimens in children with idiopathic short stature. European Study Group Participating Investigators.
    Rekers-Mombarg LT; Massa GG; Wit JM; Matranga AM; Buckler JM; Butenandt O; Chaussain JL; Frisch H; Leiberman E; Yturriaga R; Aarskog D; Chatelain PG; Colle M; Dacou-Voutetakis C; Delemarre-van de Waal HA; Girard F; Gosen JJ; Irle U; Jansen M; Jean R; Job JC; Kaar ML; Kollemann F; Lenko HL; Waelkens JJ
    J Pediatr; 1998 Mar; 132(3 Pt 1):455-60. PubMed ID: 9544901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin responsiveness to luteinizing hormone releasing hormone in prepubertal and pubertal patients with growth hormone deficiency.
    Frisch H; Waldhauser F; Havelec L; Schober E; Swoboda W; Spona J; Schernthaner G
    Acta Paediatr Scand; 1982 Jul; 71(4):579-87. PubMed ID: 6814178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose dependence of growth response to human growth hormone in growth hormone deficiency.
    Preece MA; Tanner JM; Whitehouse RH; Cameron N
    J Clin Endocrinol Metab; 1976 Mar; 42(3):477-83. PubMed ID: 1254688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
    J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone.
    Chen YD; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2001; 42(5):291-6. PubMed ID: 11729706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative rapidity of response of height, limb muscle and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency.
    Tanner JM; Hughes PC; Whitehouse RH
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):681-96. PubMed ID: 576755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group.
    De Muinck Keizer-Schrama S; Rikken B; Hokken-Koelega A; Wit JM; Drop S
    Arch Dis Child; 1994 Jul; 71(1):12-8. PubMed ID: 8067786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final height of patients with idiopathic growth hormone deficiency after long-term growth hormone treatment. Committee for Treatment of Growth Hormone Deficient Children, Growth Science Foundation, Japan.
    Hibi I; Tanaka T
    Acta Endocrinol (Copenh); 1989 Apr; 120(4):409-15. PubMed ID: 2718695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of gonadotropin responses to synthetic gonadotropin-releasing hormone in girls with idiopathic hypopituitarism.
    Foster CM; Hopwood NJ; Beitins IZ; Mendes TM; Kletter GB; Kelch RP
    J Pediatr; 1992 Oct; 121(4):528-32. PubMed ID: 1403384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment.
    Adan L; Chemaitilly W; Trivin C; Brauner R
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):297-302. PubMed ID: 11940040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
    J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
    N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature.
    Barton JS; Gardineri HM; Cullen S; Hindmarsh PC; Brook CG; Preece MA
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):619-26. PubMed ID: 7634503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.